Alpha Teknova, Inc.

TKNO · Nasdaq · SIC 2835: In Vitro & In Vivo Diagnostic Substances · Market Cap: $0.2B · 158 employees
66
SEC Filings
$5.37
Close 2026-06-01
158
Employees

Business Summary

Facilities for specific information about our commercial, office, manufacturing, and warehouse space. Ite m 3. Legal Proceedings. We are not a party to any material legal proceedings at this time. From time to time, we may become involved in various legal proceedings that arise in the ordinary course of business. For example, we may in the future become involved in legal proceedings relating to customers, employees, suppliers, competitors, government agencies, or others. We will evaluate any cla...

Latest Stock Quote

TKNO 2026-06-01 $5.37 O:$5.44 H:$5.78 L:$5.11 Vol:0.4M VWAP:$5.5049
origin leaf: 0bd8ea76bb6588cdf489dfda8634cfccda5e6b0c494d8db1917718b51e9d1e3f

Next Earnings

Q2 FY2026 — expected 2026-08-11

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-022025-12-310001850902-26-000002EDGAR61K words
2025-03-072024-12-310000950170-25-035705EDGAR
2024-03-272023-12-310000950170-24-036624EDGAR
2023-03-302022-12-310000950170-23-010926EDGAR
2022-03-182021-12-310000950170-22-004176EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-072025-09-300001193125-25-272321EDGAR22K words
2025-08-082025-06-300000950170-25-105825EDGAR
2025-05-092025-03-310000950170-25-068050EDGAR
2024-11-082024-09-300000950170-24-124159EDGAR
2024-08-132024-06-300000950170-24-096441EDGAR
2024-05-132024-03-310000950170-24-058827EDGAR
2023-11-132023-09-300000950170-23-063053EDGAR
2023-08-112023-06-300000950170-23-041875EDGAR
2023-05-112023-03-310000950170-23-021313EDGAR
2022-11-142022-09-300000950170-22-024641EDGAR
2022-08-112022-06-300000950170-22-016861EDGAR
2022-05-122022-03-310000950170-22-009650EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-260001193125-26-076592EDGAR5K words
2025-11-060001193125-25-269488EDGAR
2025-08-070000950170-25-105005EDGAR
2025-06-230000950170-25-089004EDGAR
2025-05-080000950170-25-067005EDGAR
2025-03-040000950170-25-031995EDGAR
2024-11-070000950170-24-123359EDGAR
2024-08-130000950170-24-096188EDGAR
2024-07-120000950170-24-083216EDGAR
2024-07-090000950170-24-082477EDGAR

66 total filings indexed. 39 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

ACHV — ACHIEVE LIFE SCIENCES, INC. AWHL — Aspira Women's Health Inc. BMRA — BIOMERICA INC BZYR — BURZYNSKI RESEARCH INSTITUTE INC CDIO — Cardio Diagnostics Holdings, Inc. CLDX — Celldex Therapeutics, Inc. IDXX — IDEXX LABORATORIES INC /DE ICCC — IMMUCELL CORP /DE/

Company Identity

CIK0001850902
TickerTKNO
ExchangeNasdaq
SIC2835: In Vitro & In Vivo Diagnostic Substances
IncorporatedDE
Websitehttps://www.teknova.com
Listed2021-06-25

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 54da34222d07e4bcc5597bb811214cd416d687a78cc652702a770bf787940c52
parent: 1593da9318f85840ba70f276c4ade6dc9782b318e158f832608d9df333b15f97
content hash: 2b34f061bd60d0753dae9a2c220a8f459b25fb05b7d6047ec24c8d8d5186bb1f
signed: 2026-06-02T19:02:51.152Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf